Semaglutide 0.25 mg weight loss is targeted at adult patients with a body mass index (BMI) of 30 or higher (obese) or a BMI of 27 or higher with one or more weight-associated conditions, including type 2 diabetes, high blood pressure, or dyslipidemia
When it comes to side effects, the most common by far is gastrointestinal stomach issues
Most patients report minimal to mild discomfort with GLP-1 injections used for type 2 diabetes and weight management
This can be uncomfortable and concerning, but there are ways to help prevent this side effect
But it does mean you're accepting risks that don't exist with topical application, for benefits that may not be meaningfully greater
The findings are intriguing, however, and "need to be examined in randomized, clinical trials," the researchers concluded